Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Scolaro

Orthopaedic Trauma Orange, CA Medical Doctor

NPI 1790983476 CMS profile 217780

101 The City Dr S, Building 29A, Pav III - 2Nd Floor, Orange, CA 92868

Open in the dashboard

General payments

$1,001,704

910 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$22,550 paid to institutions, not to them · program years 2019–2022

Through program year 2025, John Scolaro of Orange, CA is reported in the CMS Open Payments database as having received $1,001,704 across 910 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $22,550 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $152,880 149
2024 General $183,813 142
2023 General $183,971 164
2022 General $176,211 146
2021 General $121,112 123
2020 General $71,491 54
2019 General $112,227 132

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Scolaro
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to John Scolaro were reported at $152,880. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year John Scolaro Orthopaedic Trauma median Middle half National median
2019 $112,227 $1,475 $264–$6,401 $163
2020 $71,491 $596 $120–$4,020 $114
2021 $121,112 $919 $171–$4,697 $132
2022 $176,211 $1,547 $272–$7,240 $149
2023 $183,971 $1,330 $247–$5,875 $160
2024 $183,813 $1,288 $277–$6,797 $164
2025 $152,880 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $499,643 384 payments
  2. Zimmer Biomet Holdings, Inc. $121,382 164 payments
  3. Smith+Nephew, Inc. $116,524 92 payments
  4. Synthes GmbH $67,404 73 payments
  5. NuVasive Specialized Orthopedics, Inc. $67,011 60 payments
  6. Globus Medical, Inc. $34,560 33 payments
  7. Orthofix Medical, Inc. $33,059 51 payments
  8. IlluminOss Medical, Inc. $18,173 15 payments
  9. restor3d, inc. $14,454 9 payments
  10. Tyber Medical, LLC $10,627 3 payments
  11. Other $18,866 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $612,084 185 payments
  2. Travel and Lodging $172,478 309 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $115,025 19 payments
  4. Food and Beverage $24,581 338 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $24,324 20 payments
  6. Royalty or License $22,167 20 payments
  7. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $15,250 8 payments
  8. Honoraria $11,450 6 payments
  9. Current or prospective ownership or investment interest $3,987 2 payments
  10. Education $359 3 payments
Products named General payments · program years 2019–2025
  1. PRO $129,645 98 payments
  2. AXSOS $128,776 36 payments
  3. GAMMA $120,233 51 payments
  4. VARIAX $93,343 34 payments
  5. EVOS Trauma Plates, Screws, and Nails $86,771 60 payments
  6. T2 $84,027 23 payments
  7. T2 ALPHA $66,630 24 payments
  8. EVOS Trauma Plates, Screws, and Nails $57,861 34 payments
  9. EVOS MINI $50,706 34 payments
  10. PRECICE Intramedullary Limb Lengthening System $48,032 39 payments
  11. Other $916,788 721 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 70 billing codes

Paid by Medicare

$64,813

Medicare's payments for the services billed

Medicare patients

141

Average age 73

Services billed

296

89 women, 52 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 42%
Depression 40%
Ischemic heart disease 39%
Osteoporosis 37%
Heart failure 35%
Chronic kidney disease 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

910 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record